These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 21164382)

  • 1. Pharmacokinetics of polymyxin B in an infant with multidrug-resistant Klebsiella pneumoniae bacteremia.
    Salvatore CM; Abdelraouf K; Hsing DD; Tam VH
    Pediatr Infect Dis J; 2011 Jun; 30(6):537-9. PubMed ID: 21164382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful treatment of NDM-1 Klebsiella pneumoniae bacteraemia in a neutropenic patient.
    Chien JM; Koh TH; Chan KS; Chuah TH; Tan TT
    Scand J Infect Dis; 2012 Apr; 44(4):312-4. PubMed ID: 22126430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TDM-guided medication of polymyxin B in a patient with CRKP-induced bloodstream infection: a case report.
    Yu X; Pan J; Zhou Z; Wen X; Dai Y; Lin G; Jiao Z; Zhang C
    Eur J Clin Microbiol Infect Dis; 2021 Jan; 40(1):201-204. PubMed ID: 32661810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination of polymyxin B and minocycline against multidrug-resistant Klebsiella pneumoniae: interaction quantified by pharmacokinetic/pharmacodynamic modelling from in vitro data.
    Zhao C; Wistrand-Yuen P; Lagerbäck P; Tängdén T; Nielsen EI; Friberg LE
    Int J Antimicrob Agents; 2020 Jun; 55(6):105941. PubMed ID: 32171741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The efficacy and safety of different antimicrobial regimens in carbapenem-resistant
    Sun WM; Zhou H; Shen LS; Yang Q; Ma WJ; Zhou JY
    Zhonghua Nei Ke Za Zhi; 2019 Aug; 58(8):566-571. PubMed ID: 31365977
    [No Abstract]   [Full Text] [Related]  

  • 6. Pharmacokinetics/pharmacodynamics of systemically administered polymyxin B against Klebsiella pneumoniae in mouse thigh and lung infection models.
    Landersdorfer CB; Wang J; Wirth V; Chen K; Kaye KS; Tsuji BT; Li J; Nation RL
    J Antimicrob Chemother; 2018 Feb; 73(2):462-468. PubMed ID: 29149294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In-vivo emergence of polymyxin- B-resistant Klebsiella pneumoniae in patients with bloodstream infections.
    Braun G; Cayô R; Barbosa AC; Gales AC
    J Hosp Infect; 2016 Dec; 94(4):338-340. PubMed ID: 27686265
    [No Abstract]   [Full Text] [Related]  

  • 8. Polymyxin resistance in Klebsiella pneumoniae: multifaceted mechanisms utilized in the presence and absence of the plasmid-encoded phosphoethanolamine transferase gene mcr-1.
    Nang SC; Han ML; Yu HH; Wang J; Torres VVL; Dai C; Velkov T; Harper M; Li J
    J Antimicrob Chemother; 2019 Nov; 74(11):3190-3198. PubMed ID: 31365098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emergence of polymyxin B resistance in a polymyxin B-susceptible KPC-producing Klebsiella pneumoniae causing bloodstream infection in a neutropenic patient during polymyxin B therapy.
    Zavascki AP; Girardello R; Magagnin CM; Antochevis LC; Maciel RA; Palmeiro JK; Gales AC
    Diagn Microbiol Infect Dis; 2018 Feb; 90(2):134-138. PubMed ID: 29150371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymyxin B and fosfomycin thwart KPC-producing Klebsiella pneumoniae in the hollow-fibre infection model.
    Bulman ZP; Zhao M; Satlin MJ; Chen L; Kreiswirth BN; Walsh TJ; Nation RL; Li J; Tsuji BT
    Int J Antimicrob Agents; 2018 Jul; 52(1):114-118. PubMed ID: 29486233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics and Efficacy of Ceftazidime-Avibactam in the Treatment of Experimental Pneumonia Caused by Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae in Persistently Neutropenic Rabbits.
    Petraitiene R; Petraitis V; Kavaliauskas P; Maung BBW; Khan F; Naing E; Aung T; Zigmantaite V; Grigaleviciute R; Kucinskas A; Stakauskas R; Georgiades BN; Mazur CA; Hayden JA; Satlin MJ; Walsh TJ
    Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 32015048
    [No Abstract]   [Full Text] [Related]  

  • 12. In vitro double and triple bactericidal activities of doripenem, polymyxin B, and rifampin against multidrug-resistant Acinetobacter baumannii, Pseudomonas aeruginosa, Klebsiella pneumoniae, and Escherichia coli.
    Urban C; Mariano N; Rahal JJ
    Antimicrob Agents Chemother; 2010 Jun; 54(6):2732-4. PubMed ID: 20368401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of the meropenem MIC on the killing activity of meropenem and polymyxin B in combination against KPC-producing Klebsiella pneumoniae.
    Kulengowski B; Campion JJ; Feola DJ; Burgess DS
    J Antibiot (Tokyo); 2017 Aug; 70(9):974-978. PubMed ID: 28676713
    [No Abstract]   [Full Text] [Related]  

  • 14. Early use of polymyxin B reduces the mortality of carbapenem-resistant Klebsiella pneumoniae bloodstream infection.
    Liang Q; Huang M; Xu Z
    Braz J Infect Dis; 2019; 23(1):60-65. PubMed ID: 30796888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Temporal evolution of polymyxin B-resistant Klebsiella pneumoniae clones recovered from blood cultures in a teaching hospital during a 7-year period.
    Braun G; Cayô R; Matos AP; de Mello Fonseca J; Gales AC
    Int J Antimicrob Agents; 2018 Mar; 51(3):522-527. PubMed ID: 28887199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Triple combination antibiotic therapy for carbapenemase-producing Klebsiella pneumoniae: a systematic review.
    Jacobs DM; Safir MC; Huang D; Minhaj F; Parker A; Rao GG
    Ann Clin Microbiol Antimicrob; 2017 Nov; 16(1):76. PubMed ID: 29178957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intestinal decontamination of multidrug-resistant Klebsiella pneumoniae after recurrent infections in an immunocompromised host.
    Kronman MP; Zerr DM; Qin X; Englund J; Cornell C; Sanders JE; Myers J; Rayar J; Berry JE; Adler AL; Weissman SJ
    Diagn Microbiol Infect Dis; 2014 Sep; 80(1):87-9. PubMed ID: 25041704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of meropenem by continuous infusion to treat a patient with a Bla(kpc-2)-positive Klebsiella pneumoniae blood stream infection.
    Ho VP; Jenkins SG; Afaneh CI; Turbendian HK; Nicolau DP; Barie PS
    Surg Infect (Larchmt); 2011 Aug; 12(4):325-7. PubMed ID: 21859337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New Polymyxin B Dosing Strategies To Fortify Old Allies in the War against KPC-2-Producing Klebsiella pneumoniae.
    Bulman ZP; Satlin MJ; Chen L; Kreiswirth BN; Shin BS; Walsh TJ; Holden PN; Forrest A; Nation RL; Li J; Tsuji BT
    Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28167549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcriptomic responses of a New Delhi metallo-β-lactamase-producing Klebsiella pneumoniae isolate to the combination of polymyxin B and chloramphenicol.
    Abdul Rahim N; Cheah SE; Johnson MD; Zhu Y; Yu HH; Sidjabat HE; Butler MS; Cooper MA; Fu J; Paterson DL; Nation RL; Boyce JD; Bergen PJ; Velkov T; Li J
    Int J Antimicrob Agents; 2020 Aug; 56(2):106061. PubMed ID: 32574791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.